Searched for
PHARMACEUTICAL MERGER NEWS
Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Torrent expects JB Chemicals acquisition deal to close in 15–18 monthsTorrent Pharmaceuticals is set to acquire a major stake in J B Chemicals. The deal is expected to finalize in 15 to 18 months. This acquisi...
- Torrent Pharma to acquire JB Chemicals at Rs 25,689 crore valuationTorrent Pharma will acquire a controlling stake in JB Chemicals from KKR. The deal values JB Chemicals at Rs 25,689 crore. This merger will...
- SC seeks govt response on advancing emission standard deadline for NCR power plantsThe Supreme Court has asked the Environment Ministry if the deadline for Delhi's 'Category C' power plants to comply with sulphur dioxide e...
- Sequent Scientific, Viyash Life Sciences explore merger worth Rs 7000-8000 crSequent Scientific and Viyash Life Sciences are discussing a potential merger valued at Rs. 7000-8000 crore. Both companies' boards will me...
- Digital ecosystems to be included in Big Tech antitrust, merger probes, EU regulators sayVestager made the comment as she announced an update to nearly three-decade old rules known as the Market Definition Notice that determine ...
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- PharmEasy is closing in on $120 million in equity roundThe transaction, which is expected to close by the end of the month, will value the five-yearold company at $500-600 million, according to ...
- Cadila Healthcare, Torrent Pharma eyeing potential merger"More clarity on the proposed structure, valuations can be expected in the next six months," a source said adding that the merger may or ma...
- The 57%-a-year Chinese stock trade that regulators want to stopPrivate firms often purchase a public “shell” to take over its listing hoping they’ll turn into targets of reverse mergers. Such deals are ...
- FDI green light to spark M&As in pharma sectorUntil now to buy into an Indian enterprise, multinational drug companies needed an approval from FIPB under department of industrial policy...
- Malvinder and Shivinder Mohan Singh to contest arbitration panel order on damages to DaiichiUS subsidiary of Ranbaxy pleaded guilty to 7 felonies relating to the manufacture and distribution of certain adulterated drugs made at uni...
- 2015 in review: Mergers and acquisitions peak in pharma industry; so does regulatory glareThe year also saw the government making an attempt to expand drugs under price control by revising the list of essential medicines.
- Pharma looks best export theme, valuations attractive: Deepak ShenoyFDA plant warnings have increased of late; Trans-Pacific Partnership has reduced pharma companies' access to some pacific countries, says S...
- Strides Arcolab set to acquire Shasun Pharma in an all-stock dealShareholders of Chennai-based Shasun Pharma will receive five equity shares of Strides for every 16 equity shares they hold in the company.
- Merger with Sun Pharma will spell the end of Ranbaxy brand, but a new dawn beckonsSun Pharma may not have to face surprises emanating from Ranbaxy. There is every likelihood that brand Ranbaxy will see a sunset clause whe...
- Get rich by betting a takeover rumour is wrongWhile stocks that were the subject of takeover speculation initially jumped 2.9%, betting on declines yielded average profits of 1.2% in th...
- Templeton backs Sun in Taro bidSun Pharmaceuticals has received the support of the US-based equity fund Templeton Asset Management in its year-long legal tussle to acquir...
- Stocks to watch: Sun Pharma, Mafatlal Industries, Tata Steel, RNRL, NTPCSun Pharmaceutical won a temporary injunction from the Tel Aviv District Court on shareholders’ meeting of the Israeli company that was set...
Load More
